Invesco India Mid Cap Fund
The scheme seeks to generate capital appreciation by investing predominantly in Mid cap entities.
Growthvine rating: 4/5 — ranked #6 of 34 in category.
Fund basics
| Category | Equity: Mid Cap |
|---|
| NAV | ₹176.84 (as of 2026-10-23) |
|---|
| AUM | ₹15,780 Cr |
|---|
| Expense ratio | 1.44% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Aditya Khemani |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 365 days |
|---|
Performance & risk
| 5-year annualised return | 16.99% |
|---|
| Sharpe ratio | 0.76 |
|---|
| Standard deviation | 20.08% |
|---|
| Max drawdown | −70.84% |
|---|
| Alpha | 5.55 |
|---|
| Beta | 1.03 |
|---|
Over 5 years, captured 104.5% of NIFTY Midcap 150's upside and 97.6% of its downside.
Market cap allocation
| Large cap | 15.5% |
|---|
| Mid cap | 61.8% |
|---|
| Small cap | 22.7% |
|---|
Concentration
| Top 5 holdings | 29.8% |
|---|
| Top 10 holdings | 49.1% |
|---|
| Total holdings | 43 |
|---|
| Index overlap | 18.5% |
|---|
| Active share | 81.5% |
|---|
Top holdings
- Prestige Estates Projects Limited — 7.3%
- Max Healthcare Institute Limited — 7.2%
- Meesho Limited — 5.4%
- Federal Bank Ltd. — 5.4%
- Manipal Health Enterprises Limited — 4.4%
- Eternal Limited — 4.1%
- Global Health Limited — 4.0%
- L&T Finance Limited — 3.9%
- AU Small Finance Bank Limited — 3.8%
- IndusInd Bank Ltd. — 3.5%
Top sectors
- Retail — 23.7%
- Healthcare — 17.2%
- Banking & Financial — 16.9%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −3.6% | Q2 | #11 of 31 |
| 2025 | 6.3% | Q1 (Top) | #4 of 29 |
| 2024 | 43.1% | Q1 (Top) | #2 of 29 |
| 2023 | 34.1% | Q3 | #20 of 28 |
| 2022 | 0.5% | Q3 | #15 of 22 |